Levodopa
Photos »
/ 
Related News »
At first, in order to control his symptoms, Van Housen took a medication called levodopa. Without the medication, Van Housen could not walk or drive. He also suffered from painful muscle spasms. “The symptoms progressed worse and it got to the ...
May 21, 2012 at 23:54 | Source: FOX News
Levodopa is converted to dopamine in the brain. It is effective in managing the initial symptoms of Parkinson disease, however over time the effectiveness is reduced and this results in motor fluctuations. Motor fluctuations are periods of the day with ...
May 13, 2012 at 12:14 | Source: Psych Centra
MAO-B-Inhibitors, NMDA antagonists, dopamine agonists and levodopa with its various application modes mainly improve the dopamine associated motor symptoms in PD. This armentarium of PD drugs only partially influences the onset and occurrence of non motor symptoms.
May 24, 2012 at 09:45 | Source: 7thspace.com
If I can't get Mirapex to stabilize I can't have the six months to two years of extra drug time, and have to start the Levodopa now. Right now. I teeter. So does my Mt. Sinai pal. Do I deal with the daily seasick routine, try to live with it ...
May 25, 2012 at 06:31 | Source: Salon
To treat the initial symptoms of Parkinson disease doctors may prescribe: Levodopa or dopamine agonists: There is strong evidence* that either levodopa or a dopamine agonist can be used to treat initial symptoms. Dopamine agonists are drugs that stimulate ...
May 13, 2012 at 12:14 | Source: Psych Centra
initially for levodopa-induced dyskinesia in patients with Parkinson's disease. Both products are designed to improve tolerability and clinical efficacy, and to provide superior clinical and health economic benefits. For more information ...
May 15, 2012 at 10:53 | Source: Yahoo Finance
Both drugs are generally well tolerated but can cause nausea, dizziness, or other side effects. Good short-term results of treatment with levodopa plus carbidopa have been reported. Although dopamine-related medications are effective in managing ...
May 15, 2012 at 21:30 | Source: WKBW-TV
Addex's extensive product pipeline comprises its lead products in Phase II clinical trials are dipraglurant, an mGluR5 negative allosteric modulator to treat Parkinson's disease levodopa-induced dyskinesia (PD-LID) and ADX71149 (mGluR2 positive allosteric ...
May 12, 2012 at 10:07 | Source: Transworld News